Primer: Physician Biosimilar Prescribing

$750.00$1,125.00

Licensing Options

  • SINGLE-USER LICENSE

    A Single-User License allows access to an individual user.

  • ENTERPRISE-WIDE LICENSE

    An Enterprise-Wide License allows access to all employees and sites within an organization.

Report Overview

Q2, 2010

This primer – designed, executed and analyzed by research professionals from the drug development and commercialization industry – sheds light on prescribers’ views of biosimilars. It is based on interviews with 264 physicians in the United States and Western Europe. Respondents provided their beliefs, attitudes, intentions, and expectations on a number of biosimilar related topics including:

  • Regulatory issues
  • Safety and efficacy
  • Prescribing / Pricing
  • Development / Testing rigor
  • Differences between “generic” and “novel” manufacturers

 

What you will learn:

Sponsors and service providers can rely on this report to provide an important perspective on their development and commercialization strategies for Biosimilar products

 

Report Contents:

  1. Regulatory Awareness
  2. Safety and Efficacy
  3. Perceptions of Generic and Innovator Companies
  4. Prescribing Behavior

Questions?

Our team is here to help.

For questions about syndicated report purchases, custom research solutions, or other billing-related topics, please contact sales@ISRreports.com.